Markus Gershater, Ph.D., co-founded Synthace and currently serves as its Chief Scientific Officer. Before Synthace, Markus was a Research Associate in Synthetic Biology at University College London where he developed novel biosynthesis methods using pathway engineering. Prior to UCL, he was a Biotransformation Scientist at Novacta Biosystems working as part of the industrial biotechnology group that conducted more than 90 contract research projects for over 20 clients.